Citation Impact
Citing Papers
Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages
2011
T cell metabolism drives immunity
2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite
2005 Science
MRI criteria for MS in patients with clinically isolated syndromes
2010
Dendritic Cells Amplify T Cell-Mediated Immune Responses in the Central Nervous System
2006
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Pathologic heterogeneity persists in early active multiple sclerosis lesions
2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
2014
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
2013
Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment
2000
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
2002 Standout
Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis
2003
Therapeutic effects of glatiramer acetate and grafted CD115+monocytes in a mouse model of Alzheimer’s disease
2015
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses
2005
Pediatric multiple sclerosis
2009
Design of effective immunotherapy for human autoimmunity
2005 Nature
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”
2006
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
2011
Neuromyelitis Optica
2010
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
2009
Immunity and cognition: what do age-related dementia, HIV-dementia and ‘chemo-brain’ have in common?
2008
Ulcerative Colitis
2011 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
2005
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
2013
Guillain-Barré syndrome
2016 Standout
Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis
2013
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes
2001
Diagnosis of multiple sclerosis: progress and challenges
2016
Pediatric Multiple Sclerosis
2011
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis
2000
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Novel bifunctional probe for radioisotope-free photoaffinity labeling: compact structure comprised of photospecific ligand ligation and detectable tag anchoring unitsElectronic supplementary information (ESI) available: Photo-decomposition study of phenyl and benzyl azides. Experimental details for photoreactions of 1 and 5. Synthetic procedures and characterization of new compounds. See http://www.rsc.org/suppdata/ob/b3/b316221d/.
2004
Systemic inflammatory cells fight off neurodegenerative disease
2010
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
2012
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain–Barré syndrome associated with accumulation of proteolytically active lymphocytes in blood
2001
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
2006
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
2006
Platelet Activation and Atherothrombosis
2007 Standout
Lymphatic drainage of the brain and the pathophysiology of neurological disease
2008
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation
2015
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
2015
New natural history of interferon‐β–treated relapsing multiple sclerosis
2007
The immune system in atherosclerosis
2011 Standout
Graves' Ophthalmopathy
2010 Standout
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics
2007
Host Defense against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis
2011
Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial
2013
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis
1999
Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice
2009
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
2003
Adaptive immunity and atherosclerosis
2009
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
The immune response in atherosclerosis: a double-edged sword
2006 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
The blood–brain barrier
2016
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
2005
Alzheimer's Disease
2010 Standout
Tryptophan degradation in autoimmune diseases
2007
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
2008
Origin and physiological roles of inflammation
2008 StandoutNature
Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction
2009
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
2010
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
2004
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
A FRET‐Based Fluorogenic Phosphine for Live‐Cell Imaging with the Staudinger Ligation
2008 StandoutNobel
The anatomical and cellular basis of immune surveillance in the central nervous system
2012
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
2006
Myeloid cells — targets of medication in multiple sclerosis
2016
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
2012
JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
2008
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex—bound immunogenic peptides induced by interferon-α and interferon-γ treatment of human glioblastoma multiforme
2004
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation
2008
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Biomarkers in multiple sclerosis
2015
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis
2017
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
2009
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions
2007
Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity
2010
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
2015
Localizing central nervous system immune surveillance: Meningeal antigen‐presenting cells activate T cells during experimental autoimmune encephalomyelitis
2008
TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis
2007
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
2006
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
2006
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS
2001
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
2019
Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab
2011
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
The Inflamed Central Nervous System Drives the Activation and Rapid Proliferation of Foxp3+ Regulatory T Cells
2007
Stromal-derived factor 1–induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases
2000
Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis
2007
Multiple Sclerosis
2018 Standout
Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
2013
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice
2010
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Hidden fluid mechanics: Learning velocity and pressure fields from flow visualizations
2020 StandoutScience
Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus
2006
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment
2000
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
2009
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Multiple sclerosis
2004
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity
2014
Fatal PML associated with efalizumab therapy
2012
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Devic’s neuromyelitis optica: a critical review
2008
Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin
2003
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Statin-Induced Proinflammatory Response in Mitogen-Activated Peripheral Blood Mononuclear Cells through the Activation of Caspase-1 and IL-18 Secretion in Monocytes
2006
INFLAMMATION AND ATHEROSCLEROSIS
2006
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
2010
Works of Olaf Stüve being referenced
Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T‐cell activation
2001
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro
2005
Acute Disseminated Encephalomyelitis
2005
Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9
1996
Plasma Exchange in Neuroimmunological Disorders
2006
Optical coherence tomography in multiple sclerosis
2006
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
2007
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
2013
Immunopathogenesis of Neuromyelitis Optica
2014
The effects of natalizumab on the innate and adaptive immune system in the central nervous system
2008
Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA)
2002
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
2002 Nature
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
2013
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician
2008
Natalizumab and Progressive Multifocal Leukoencephalopathy
2010
Treatment of neuromyelitis optica: Review and recommendations
2012
Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab
2009
Putative mechanisms of action of statins in multiple sclerosis – comparison to interferon-β and glatiramer acetate
2005
Immune surveillance in multiple sclerosis patients treated with natalizumab
2006
Plasma Exchange in Neuroimmunological Disorders
2006
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9
1997
Pharmacological Treatment of Early Multiple Sclerosis
2008
Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis
2005
Lymph node-derived donor encephalitogenic CD4+T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet
2011
Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
2010
Statins in the treatment of central nervous system autoimmune disease
2006
Therapeutic Considerations for Disease Progression in Multiple Sclerosis
2005
Characterizing the Mechanisms of Progression in Multiple Sclerosis
2005
Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity
2001
Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis
2006
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis
2016
Interferon beta in the treatment of multiple sclerosis
1998
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
2014
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
2014
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
2017
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease
2002
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
2008
B lymphocytes in neuromyelitis optica
2015
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor
2000